GO:0004812 | aminoacyl-tRNA ligase activity | 5.26% (9/171) | 3.98 | 0.0 | 0.0 |
GO:0043039 | tRNA aminoacylation | 5.26% (9/171) | 3.98 | 0.0 | 0.0 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 5.26% (9/171) | 3.98 | 0.0 | 0.0 |
GO:0043038 | amino acid activation | 5.26% (9/171) | 3.98 | 0.0 | 0.0 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.26% (9/171) | 4.11 | 0.0 | 0.0 |
GO:0140098 | catalytic activity, acting on RNA | 7.02% (12/171) | 3.12 | 0.0 | 0.0 |
GO:0016874 | ligase activity | 6.43% (11/171) | 3.19 | 0.0 | 1e-06 |
GO:0006399 | tRNA metabolic process | 5.85% (10/171) | 3.3 | 0.0 | 2e-06 |
GO:0140101 | catalytic activity, acting on a tRNA | 5.26% (9/171) | 3.51 | 0.0 | 2e-06 |
GO:0034660 | ncRNA metabolic process | 5.85% (10/171) | 2.96 | 1e-06 | 1.5e-05 |
GO:0006520 | cellular amino acid metabolic process | 5.26% (9/171) | 2.69 | 1e-05 | 0.000247 |
GO:0016070 | RNA metabolic process | 9.36% (16/171) | 1.82 | 1.2e-05 | 0.000271 |
GO:0019752 | carboxylic acid metabolic process | 5.85% (10/171) | 2.45 | 1.5e-05 | 0.000287 |
GO:0043436 | oxoacid metabolic process | 5.85% (10/171) | 2.45 | 1.5e-05 | 0.000287 |
GO:0006082 | organic acid metabolic process | 5.85% (10/171) | 2.42 | 1.7e-05 | 0.000311 |
GO:1901265 | nucleoside phosphate binding | 15.2% (26/171) | 1.28 | 2.2e-05 | 0.00034 |
GO:0000166 | nucleotide binding | 15.2% (26/171) | 1.28 | 2.2e-05 | 0.00034 |
GO:0043168 | anion binding | 15.79% (27/171) | 1.25 | 2e-05 | 0.000352 |
GO:0036094 | small molecule binding | 15.79% (27/171) | 1.23 | 2.7e-05 | 0.000398 |
GO:0097367 | carbohydrate derivative binding | 12.87% (22/171) | 1.31 | 6.9e-05 | 0.000868 |
GO:0032553 | ribonucleotide binding | 12.87% (22/171) | 1.32 | 6.4e-05 | 0.000882 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 2.92% (5/171) | 3.5 | 6.8e-05 | 0.000899 |
GO:0090304 | nucleic acid metabolic process | 9.36% (16/171) | 1.5 | 0.000174 | 0.002088 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.75% (3/171) | 4.57 | 0.000206 | 0.002101 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.75% (3/171) | 4.57 | 0.000206 | 0.002101 |
GO:0000398 | mRNA splicing, via spliceosome | 1.75% (3/171) | 4.57 | 0.000206 | 0.002101 |
GO:0030554 | adenyl nucleotide binding | 10.53% (18/171) | 1.34 | 0.000263 | 0.002137 |
GO:0032559 | adenyl ribonucleotide binding | 10.53% (18/171) | 1.34 | 0.000256 | 0.002143 |
GO:0008144 | drug binding | 11.11% (19/171) | 1.3 | 0.00025 | 0.002154 |
GO:0043167 | ion binding | 19.88% (34/171) | 0.91 | 0.000192 | 0.002208 |
GO:0046540 | U4/U6 x U5 tri-snRNP complex | 1.17% (2/171) | 5.98 | 0.000249 | 0.002216 |
GO:0004329 | formate-tetrahydrofolate ligase activity | 1.17% (2/171) | 5.98 | 0.000249 | 0.002216 |
GO:0097526 | spliceosomal tri-snRNP complex | 1.17% (2/171) | 5.98 | 0.000249 | 0.002216 |
GO:0005524 | ATP binding | 10.53% (18/171) | 1.36 | 0.00023 | 0.002263 |
GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer | 1.75% (3/171) | 4.4 | 0.000305 | 0.002273 |
GO:1901363 | heterocyclic compound binding | 20.47% (35/171) | 0.86 | 0.000297 | 0.002278 |
GO:0097159 | organic cyclic compound binding | 20.47% (35/171) | 0.86 | 0.000297 | 0.002278 |
GO:0035639 | purine ribonucleoside triphosphate binding | 11.7% (20/171) | 1.22 | 0.000345 | 0.002509 |
GO:0032555 | purine ribonucleotide binding | 11.7% (20/171) | 1.21 | 0.00038 | 0.002689 |
GO:0017076 | purine nucleotide binding | 11.7% (20/171) | 1.2 | 0.000427 | 0.002948 |
GO:0097525 | spliceosomal snRNP complex | 1.17% (2/171) | 5.4 | 0.000739 | 0.004742 |
GO:0030532 | small nuclear ribonucleoprotein complex | 1.17% (2/171) | 5.4 | 0.000739 | 0.004742 |
GO:0120114 | Sm-like protein family complex | 1.17% (2/171) | 5.4 | 0.000739 | 0.004742 |
GO:0006139 | nucleobase-containing compound metabolic process | 9.36% (16/171) | 1.27 | 0.001007 | 0.006318 |
GO:0008380 | RNA splicing | 1.75% (3/171) | 3.76 | 0.001246 | 0.007642 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 1.17% (2/171) | 4.98 | 0.001462 | 0.008587 |
GO:0004486 | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 1.17% (2/171) | 4.98 | 0.001462 | 0.008587 |
GO:0044281 | small molecule metabolic process | 5.85% (10/171) | 1.6 | 0.001782 | 0.010246 |
GO:0003824 | catalytic activity | 26.32% (45/171) | 0.6 | 0.002105 | 0.011854 |
GO:0005488 | binding | 27.49% (47/171) | 0.57 | 0.002586 | 0.013728 |
GO:0046483 | heterocycle metabolic process | 9.36% (16/171) | 1.14 | 0.002505 | 0.013825 |
GO:0006725 | cellular aromatic compound metabolic process | 9.36% (16/171) | 1.14 | 0.002559 | 0.013851 |
GO:1901360 | organic cyclic compound metabolic process | 9.36% (16/171) | 1.08 | 0.003733 | 0.019442 |
GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 1.17% (2/171) | 4.17 | 0.00496 | 0.024892 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 1.17% (2/171) | 4.17 | 0.00496 | 0.024892 |
GO:0006612 | protein targeting to membrane | 1.17% (2/171) | 3.98 | 0.006545 | 0.031146 |
GO:0006613 | cotranslational protein targeting to membrane | 1.17% (2/171) | 3.98 | 0.006545 | 0.031146 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.17% (2/171) | 3.98 | 0.006545 | 0.031146 |
GO:0006397 | mRNA processing | 1.75% (3/171) | 2.87 | 0.007744 | 0.036226 |
GO:0072599 | establishment of protein localization to endoplasmic reticulum | 1.17% (2/171) | 3.81 | 0.008328 | 0.037074 |
GO:0070972 | protein localization to endoplasmic reticulum | 1.17% (2/171) | 3.81 | 0.008328 | 0.037074 |
GO:0045047 | protein targeting to ER | 1.17% (2/171) | 3.81 | 0.008328 | 0.037074 |
GO:0016071 | mRNA metabolic process | 1.75% (3/171) | 2.71 | 0.010514 | 0.04606 |
GO:0016746 | transferase activity, transferring acyl groups | 2.92% (5/171) | 1.89 | 0.011089 | 0.04782 |